Rachel Archer shared her journey online, racking up 1.2 million views. She told Newsweek she was motivated to raise awareness ...

A 14-gene assay predicts chemotherapy benefit in early-stage non-small-cell lung cancer, improving 24-month disease-free ...

New research reveals that combining lurbinectedin with atezolizumab significantly improves survival rates for patients with ...

Studies presented at the ASCO Annual Meeting 2025 highlighted immunotherapies that may provide new standards of care for certain cancers as well as immunotherapies that are breaking new ground by ...

Cancer is not a welcome diagnosis, but breakthroughs in genetic sequencing and immunotherapy are making some cancers easier ...

The majority of patients with the most common advanced or metastatic cancers in the United States do not undergo ...

Results of a meta-analysis suggest that ctDNA positivity is a “biomarker for poor postoperative recurrence and survival outcomes in NSCLC patients,” researchers wrote.

Anlotinib combined with immune checkpoint inhibitors may benefit patients with extensive-stage small cell lung cancer treated ...

CHEST guideline updates support minimally invasive resection and targeted therapy to enhance survival in Stage I–II NSCLC.

The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an ...

David Roach has shared a shocking health update. The Junkyard frontman and his fiancée, Jennifer, took to Instagram on ...

Appendix cancer is a rare but increasingly recognized malignancy, often discovered incidentally during surgery for presumed ...